News Entero Therapeutics, Inc.

Equities

ENTO

US33749P4081

Market Closed - Nasdaq Other stock markets 21:30:00 14/06/2024 BST			5-day change	1st Jan Change
2.07 ^USD	-5.91%		-15.25%	-50.71%

05-20	Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index	CI
05-17	First Wave BioPharma, Inc. will Change its Name to Entero Therapeutics, Inc	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention	05-22	AQ
Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index	05-19	CI
First Wave BioPharma, Inc. will Change its Name to Entero Therapeutics, Inc	05-17	CI
First Wave BioPharma Changes Name to Entero Therapeutics	05-16	AQ
First Wave BioPharma, Inc.(NasdaqGM:ENTO) dropped from NASDAQ Composite Index	05-15	CI
First Wave BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market	05-10	AQ
First Wave BioPharma, Inc. announced a financing transaction	05-09	CI
First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month	05-09	AQ
First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients	04-24	AQ
First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase	04-17	AQ
First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference	04-15	AQ
First Wave BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference	03-18	AQ
Sector Update: Health Care Stocks Retreating Late Afternoon	03-14	MT
Sector Update: Health Care	03-14	MT
First Wave BioPharma Shares Fall After Acquiring ImmunogenX	03-14	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Inflation Data	03-14	MT
First Wave Biopharma, Inc. Announces Management Changes	03-14	CI
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline	03-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Entero Therapeutics, Inc.

Equities

ENTO

US33749P4081

Summary

Filters